TORONTO – LYTE Clinic is proud to join University Health Network and Medical Cannabis by Shoppers in a first-of-its-kind Real World Evidence study with medical cannabis.
The Medical Cannabis Real-World Evidence (MC-RWE) clinical trial will allow patients to select medical cannabis products that are tested, from seed straight through to packaging. Patients using the online portal created by Medical Cannabis by Shoppers, will know exactly what is in their product: how many milligrams of THC and cannabidiol are being consumed, and if it works for them, they can rely on the product being exactly the same, from batch to batch. Patients in the MC-RWE clinical trial will have access to a wide range of products including dried flower, oil extracts, edibles, and topical preparations through the portal, which is the online platform for the sale of medical cannabis by Canadian retail pharmacy chain, Shoppers Drug Mart.
LYTE Clinics’ practitioners will assist patients in enrolling in the study, as well as offering support and medical advice to participants so that they can select the best products for their medical cannabis therapy.
LYTE is unique amongst cannabis clinics as the process of scheduling an appointment with a doctor, registering with a medical provider, and placing an order is all done online in a matter of minutes, using state-of-art telehealth software, with the benefit of minimizing wait time.
“LYTE’s robust telemedicine platform will connect Canada’s largest pharmacy network, Shoppers Drug Mart, with Canada’s largest and most prestigious research